Alkindi® granules in capsules for opening is the first hydrocortisone product licensed solely for paediatric use for replacement therapy of adrenal insufficiency in infants, children and…
NPPG and RCPCH strongly recommend that when children require unlicensed liquid medications, they should receive the RCPCH- and NPPG- recommended strength, where one exists. There…
This article outlines the available spontaneous adverse drug event data for progressive multifocal leukoencephalopathy (PML), a rare but life-threatening demyelinating disease, with respect to biological…
This is a practical demonstration of team working where like-minded individuals from three disciplines formed a Tripartite alliance to reduce medication errors. Working together has…